Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tongji Hospital
TG Therapeutics, Inc.
Umeå University
Reunion Neuroscience Inc
University of Iowa
Gilead Sciences
Tianjin Huanhu Hospital
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Brain Inflammation Collaborative
Tongji Hospital
Tongji Hospital
University of Pittsburgh
Mayo Clinic
Reveal Pharmaceuticals Inc.
Centre Hospitalier Régional d'Orléans
Tianjin Huanhu Hospital
Accelerated Cure Project for Multiple Sclerosis
Endeavor Health
University of Alabama at Birmingham
ProgenaBiome
RenJi Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of California, Davis
Centre Hospitalier Universitaire de Nice
University of California, San Francisco
New York Stem Cell Foundation Research Institute
Burke Medical Research Institute
Fondazione Don Carlo Gnocchi Onlus
Xuanwu Hospital, Beijing
University of Bern
University of British Columbia
Tongji Hospital
VitaMed Research LLC
Tongji Hospital
Xuanwu Hospital, Beijing
Click Therapeutics, Inc.
Sanguine Biosciences
Sanguine Biosciences
University Medical Center Groningen
Atara Biotherapeutics
IRCCS Fondazione Stella Maris
Global Healthy Living Foundation
Casa Colina Hospital and Centers for Healthcare
King's College London
University of Texas Southwestern Medical Center
Bayer
University of Iowa
Click Therapeutics, Inc.
Alliance Foundation Trials, LLC.